Risk factors for development of new-onset diabetes mellitus in pediatric renal transplant recipients: An analysis of the OPTN/UNOS database

Transplantation

Volumn 89, Issue 4, 2010, Pages 434-439

  Kuo, Hung Tien ^a,b   Poommipanit, Neda ^a   Sampaio, Marcelo ^a,c   Reddy, Pavani ^a   Cho, Yong W ^d   Bunnapradist, Suphamai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d National Institute of Transplantation Los Angeles   (United States)

Author keywords

Diabetes mellitus; Pediatric renal transplant; Posttransplant complications; Risk factors

Indexed keywords

STEROID;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CHILD; DATA BASE; DIABETES MELLITUS; DISEASE FREE SURVIVAL; DRUG USE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HAZARD RATIO; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCHOOL CHILD;

ADOLESCENT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MEDICAL HISTORY TAKING; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 77649139765     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c47a91     Document Type: Article

References (33)

1. Abbott KC, Lentine KL, Bucci JR, et al. Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus. J Am Soc Nephrol 2004; 15: 3166.
2. Friedman EA, Shyh TP, Beyer MM, et al. Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 1985; 5: 196.
3. Vesco L, Busson M, Bedrossian J, et al. Diabetes mellitus after renal transplantation: Characteristics, outcome, and risk factors. Transplantation 1996; 61: 1475.
4. Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178.
5. Cosio FG, Hickson LJ, Griffin MD, et al. Patient survival and cardiovascular risk after kidney transplantation: The challenge of diabetes. Am J Transplant 2008; 8: 593.
6. Cosio FG, Pesavento TE, Kim S, et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002; 62: 1440.
7. Schiel R, Heinrich S, Steiner T, et al. Long-term prognosis of patients after kidney transplantation: A comparison of those with or without diabetes mellitus. Nephrol Dial Transplant 2005; 20: 611.
8. Mollar-Puchades MA, Malek-Marin T, Merino-Torres JF, et al. Diabetes mellitus after kidney transplantation: Role of the impaired fasting glucose in the outcome of kidney transplantation. J Endocrinol Invest 2009; 32: 263.
9. Montori VM, Basu A, Erwin PJ, et al. Posttransplantation diabetes: A systematic review of the literature. Diabetes Care 2002; 25: 583.
10. Al-UzriA, Stablein DM, A. Cohn R. Posttransplant diabetes mellitus in pediatric renal transplant recipients: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 2001; 72: 1020.
11. Trompeter R, Filler G, Webb NJ, et al. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol 2002; 17: 141.
12. Prokai A, Fekete A, Kis E, et al. Post-transplant diabetes mellitus in children following renal transplantation. Pediatr Transplant 2008; 12: 643.
13. Filler G. Calcineurin inhibitors in pediatric renal transplant recipients. Paediatr Drugs 2007; 9: 165.
14. Shapiro R, Scantlebury V, Jordan ML, et al. Posttransplant diabetes in pediatric recipients on tacrolimus. Transplantation 1999; 67: 771.
15. Shah T, Kasravi A, Huang E, et al. Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation 2006; 82: 1673.
16. Sumrani NB, Delaney V, Ding ZK, et al. Diabetes mellitus after renal transplantation in the cyclosporine era-An analysis of risk factors. Transplantation 1991; 51: 343.
17. Bloom RD, Crutchlow MF. New-onset diabetes mellitus in the kidney recipient: Diagnosis and management strategies. Clin J Am Soc Nephrol 2008; 3(suppl 2): S38.
18. Araki M, Flechner SM, Ismail HR, et al. Posttransplant diabetes melli-tus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. Transplantation 2006; 81: 335.
19. Bhargava SK, Sachdev HS, Fall CH, et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 2004; 350: 865.
20. Barker DJ. The developmental origins of insulin resistance. Horm Res 2005; 64(suppl 3): 2.
21. Forsen T, Eriksson J, Tuomilehto J, et al. The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med 2000; 133: 176.
22. Fabrizi F, Messa P, Martin P, et al. Hepatitis C virus infection and post-transplant diabetes mellitus among renal transplant patients: A meta-analysis. Int J Artif Organs 2008; 31: 675.
23. van Hooff JP, Christiaans MH, van Duijnhoven EM. Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation 2005; 79: 1465.
24. Vincenti F, Friman S, Scheuermann E, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007; 7: 1506.
25. Johnson C, Ahsan N, Gonwa T, et al. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 2000; 69: 834.
26. Hjelmesaeth J, Hartmann A, Kofstad J, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997; 64: 979.
27. Hjelmesaeth J, Hartmann A, Kofstad J, et al. Tapering off prednisolone and cyclosporin the first year after renal transplantation: The effect on glucose tolerance. Nephrol Dial Transplant 2001; 16: 829.
28. Sulanc E, Lane JT, Puumala SE, et al. New-onset diabetes after kidney transplantation: An application of 2003 International Guidelines. Transplantation 2005; 80: 945.
29. Teutonico A, Schena PF, Di Paolo S. Glucose metabolism in renal transplant recipients: Effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol 2005; 16: 3128.
30. Johnston O, Rose CL, Webster AC, et al. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 2008; 19: 1411.
31. Li L, Chang A, NaesensM, et al. Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits. Am J Transplant 2009; 9: 1362.
32. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mel-litus in children and adolescents. J Pediatr 2005; 146: 693.
33. Dabelea D, Bell RA, D'Agostino RB Jr, et al. Incidence of diabetes in youth in the United States. JAMA 2007; 297: 2716.